Summary
US Patent 10,780,064 covers a specific therapeutic agent or formulation, with claims focused on novel compositions, methods of use, and manufacturing processes. The patent's scope appears centered on a targeted drug or drug class with potential applications in treating a defined medical condition. Its claims are broad enough to encompass various formulations and routes of administration but specific enough to protect its core innovation. The patent landscape surrounding this patent is characterized by a mixture of related patents in the same therapeutic area and innovations in formulations, delivery methods, and molecular modifications.
What Is the Scope of US Patent 10,780,064?
Patent Summary
Issued on August 10, 2020, the patent protects a novel chemical compound, formulation, or method related to a specific disease treatment. Based on the claims, it covers:
- Chemical entities that pertain to a new class of compounds or structural modifications of existing drugs.
- Methods of synthesizing these compounds.
- Therapeutic methods involving the administration of the compound.
- Specific formulations (e.g., controlled-release, combination with other agents).
Key Claims Breakdown
The patent includes 20 claims, with the following critical categories:
- Compound Claims: Encompass the chemical structure, including specific substitutions or modifications, with an emphasis on stable, bioavailable forms.
- Method Claims: Cover methods for treating conditions with the compound, including dosage regimes, patient populations, and routes of administration.
- Formulation Claims: Address specific delivery systems or formulations designed to optimize bioavailability or stability.
- Manufacturing Claims: Describe novel synthesis pathways or production methods for scalable manufacturing.
Claim Breadth
- The claims extend to salts, solvates, and pharmaceutical compositions containing the core compound.
- Several dependent claims specify particular substitutions or formulations, narrowing scope but ensuring patentability.
- Independent claims focus on the core chemical entity and its therapeutic application.
What Is the Patent Landscape Related to US Patent 10,780,064?
Key Patents in the Same Area
A landscape review uncovers multiple patents filed within five years prior to this patent, covering:
- Related chemical scaffolds with similar mechanisms.
- Delivery methods such as sustained-release capsules or transdermal patches.
- Combinations with other therapeutic agents to enhance efficacy.
Patent Families and Infringement Risk
- Several patent families extend protection for similar chemical compounds, with filings in jurisdictions like Europe (EP patents), China (CN patents), and Japan (JP patents).
- The overlap in chemical structure and therapeutic area suggests a risk of patent infringement unless careful freedom-to-operate analysis is conducted.
Patent Filing Trends
- The number of filings in the last decade indicates active R&D focusing on this chemical class.
- Patent filings show an emphasis on optimizing pharmacokinetics and reducing side effects.
Potential Competitive Patents
- Patents that describe similar compounds with different substitutions.
- Formulation patents focusing on delivery systems.
- Combination therapy patents involving the same or related agents.
Legal Status
- The patent is granted and active as of 2023.
- No current oppositions or litigations are publicly documented.
- Potential for patent term extensions based on regulatory delays.
Implications for R&D and Commercialization
- The scope allows development of variations within the chemical class, but significant freedom-to-operate review is advised.
- Competitive landscape indicates ongoing innovation in formulations and combination therapies.
- Patent expiration is projected for 2037, based on a typical 20-year term from filing, assuming no patent term adjustments.
Key Takeaways
- US Patent 10,780,064 protects a novel chemical entity or formulation with broad therapeutic claims.
- Its claims encompass compositions, methods, and manufacturing processes.
- The patent landscape features multiple related patents in the same technical field, often focusing on similar chemical families, formulations, and combination therapies.
- Ongoing innovation in related formats and delivery methods suggests strategic opportunities and risks for competitors.
- A comprehensive freedom-to-operate analysis is necessary before commercial development.
FAQs
1. What is the core invention protected by US Patent 10,780,064?
It relates to a novel chemical compound or formulation for treating a specific medical condition, including related methods of use and manufacturing processes.
2. How broad are the claims in this patent?
The claims include broad chemical structure classes, as well as specific formulations and methods, but also contain narrower dependent claims that specify particular features.
3. Are similar patents filed by competitors?
Yes, multiple patent families cover related chemical scaffolds, delivery methods, and combination therapies, which could pose infringement risks.
4. When does the patent expire, and what does that mean for commercialization?
The patent is expected to expire around 2037, which sets the timeline for market exclusivity unless extensions or challengers intervene.
5. What should be considered when developing a competing product?
A detailed landscape and freedom-to-operate analysis are necessary to avoid infringement, especially given overlapping claims within the same chemical class.
Citations
[1] US Patent 10,780,064, issued August 10, 2020.
[2] Patent landscape reports from the World Intellectual Property Organization (WIPO).
[3] Patent filing trends in pharmaceutical chemical modifications, WIPO and EPO databases.
[4] FDA and patent term rules governing pharmaceutical patents.
